Another flop for Alzeimer’s as Late Stage drug of AxovantSciences fails in trial Axovant Sciences has reported the failure of their late-stage trial involving the testing of…
Month: September 2017
Sep 25 
Anaplastic Astrocytoma: The rare disease with huge unmet medical need
Anaplastic Astrocytoma (AA) is a rare type of malignant brain tumor. As per World Health Organization (WHO) grading system, AA is classified Grade III astrocytomas. Grade…
Sep 22 
Isocitrate dehydrogenase (IDH) inhibitors– Emerging Anti-Cancer Therapeutics
The enzyme, isocitrate dehydrogenase (IDH) catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate and CO2. It is found in the cytosol, mitochondrial matrix, and peroxisomes. IDH…
Sep 20 
Business Cocktail
Chinese pharma company Shanghai Fosun to acquire 74% stake in Indian company Gland Pharma for $1.09 billion In July last year Chinese company Shanghai Fosun Pharmaceutical…
Sep 18 
Oral Mucositis – A Common Cancer Therapy Adverse Reaction
Oral Mucositis is a commonly occurring, most debilitating complication of cancer chemotherapy and radiotherapy. It can be characterized by inflammation and ulceration in the oral cavity…
Sep 15 
Human Papillomavirus (HPV) Prophylaxis– Expected to see a steady growth from 2015-2025
A total of approximately 7.3 Million people were vaccinated with HPV vaccines in 2016, as per the latest report of DelveInsight. Human Papillomavirus is a double…
Sep 15 
Business cocktail
Bayer and Berkeley Lights embark on a project to automate drug discovery Pharmaceutical giant Bayer and Berkeley Lights have announced their collaboration to conduct a strategic…
Sep 13 
The Snippet: South Korean researchers Lobbying to influence lift of human-embryo restrictions
It has been more than 10 years that a scandal related to stem cell research rocked South Korea, leading to a ban on human embryo research,…
